Publications
Below is a list of research publications published in scientific journals by IDDO and WWARN and our research partners. Use the filters to explore the publications by research theme or by using our list of key words. If you cannot find a publication, please email info@iddo.org
Pneumococcal density and respiratory co-detection in severe pediatric pneumonia in Laos
Dubot-Pérès, A., Lee, S., Dance, D., Satzke, C., Moore, K., Pell, C., Ortika, B., Nation, M., Dunne, E., Vilivong, K., Bounkhoun, T., Phommachan, S., Lim, R., Lai, J., Morpeth, M., Mayxay, M., de Lamballerie, X., Newton, P., & Russell, F. (2025). Scientific Reports, 15(1).
Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion
Wasakul, V., Verschuuren, T., Thuy-Nhien, N., Booth, E., Quang, H., Thang, N., Chindavongsa, K., Sovannaroth, S., Banouvong, V., Sengsavath, V., Mayxay, M., Tuyen, N., Phuong, V., Duc Trung, P., Gonçalves, S., Chen, S., Phalivong, S., Xayvanghang, S., Mahaphontrakoon, S., … Miotto, O. (2025). Nature Communications, 16(1).
Detection of Mycoplasma pneumoniae in hospitalized children with pneumonia in Laos
Vilivong, K., Mayxay, M., Dance, D., De Lamballerie, X., Newton, P., & Dubot-Pérès, A. (2025). Wellcome Open Research, 8, 533.
Efficacy of artemisinin-based combination therapy (ACT) in people living with HIV (PLHIV) diagnosed with uncomplicated Plasmodium falciparum malaria in Africa: a WWARN systematic review.
Takyi, A., Soma, A., Przybylska, M., Harriss, E., Barnes, K., Dahal, P., Guérin, P., Stepniewska, K., & Carrara, V. (2025). Malaria Journal, 24(1), 153.
Safety and efficacy of single-dose primaquine to interrupt Plasmodium falciparum malaria transmission in children compared with adults: a systematic review and individual patient data meta-analysis.
Yilma, D., Stepniewska, K., Bousema, T., Drakeley, C., Eachempati, P., Guerin, P., Mårtensson, A., Mwaiswelo, R., Taylor, W., Barnes, K., & WWARN Paediatric Primaquine for P falciparum Transmission Blocking Study Group. (2025). The Lancet. Infectious Diseases, S1473 - 3099(25)00078.
Defining the noma research agenda
Galli, A., Comparet, M., Dagne, D., Baratti-Mayer, D., Cao, T., Guérin, P., Guevara, M., Hetzel, M., Jeantet, C., Mpinga, E., Muendane, V., Okanlawon, M., Placella, E., Ribes, M., Sherlock, M., Utzinger, J., & Steinmann, P. (2025). PLoS Neglected Tropical Diseases, 19(4).
Hide and seek with falsified medicines: Current challenges and physico-chemical and biological approaches for tracing the origin of trafficked products.
Perez-Mon, C., Hauk, C., Roncone, A., Bontempo, L., Kelly, S., Caillet, C., Deats, M., Ogden, R., & Newton, P. (2025). Forensic Science International, 370, 112474.
Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.
Watson, J., Mehdipour, P., Moss, R., Jittamala, P., Zaloumis, S., Price, D., Dini, S., Hanboonkunupakarn, B., Leungsinsiri, P., Poovorawan, K., Chotivanich, K., Bancone, G., Commons, R., Day, N., Pukrittayakamee, S., Taylor, W., White, N., & Simpson, J. (2025). Antimicrobial Agents and Chemotherapy, 69(4), e0154924.
Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14 805 care homes in England
Chen, S., Creswell, R., Hounsell, R., Cantrell, L., Bajaj, S., Dahal, P., Tsui Lok Hei, J., Kolade, O., Amswych, M., Naidoo, R., Fowler, T., Hopkins, S., Stepniewska, K., Voysey, M., White, L., Shretta, R., & Lambert, B. (2025). BMJ Public Health, 3(1).
Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression
Howard, K., Anderson, W., Podichetty, J., Gould, R., Boyce, D., Dasher, P., Evans, L., Kao, C., Kumar, V., Hamilton, C., Mathé, E., Guerin, P., Dodd, K., Mehta, A., Ortman, C., Patil, N., Rhodes, J., Robinson, M., Stone, H., & Heavner, S. (2025). International Journal of Environmental Research and Public Health, 22(4).
Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens
Walker, T., Watson, J., Moore, D., Frick, M., & Jamrozik, E. (2025). Lancet Infectious Diseases, 25(7), e432 - e438.
Detection of Mycoplasma pneumoniae in hospitalized children with pneumonia in Laos
Vilivong, K., Mayxay, M., Dance, D., De Lamballerie, X., Newton, P., & Dubot-Pérès, A. (2025). Wellcome Open Research, 8, 533.
Submicroscopic malaria in pregnancy and associated adverse pregnancy events: A case-cohort study of 4,352 women on the Thailand–Myanmar border
Gilder, M., Saito, M., Haohankhunnatham, W., Ling, C., Gornsawun, G., Bancone, G., Chu, C., Christensen, P., Imwong, M., Charunwatthana, P., Tun, N., Min, A., Carrara, V., Proux, S., White, N., Nosten, F., & McGready, R. (2025). PLoS Medicine, 22(3).
Stop searching and you will find it: Search-Resistant Concepts in systematic review searches.
Shokraneh, F. (2025). BMJ Evidence-Based Medicine, 30(2), 134-137.
Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry
Arman, B., Clarke, R., Bharucha, T., Fernandez, L., Walsby-Tickle, J., Deats, M., Mosca, S., Lin, Q., Banerjee, S., Chunekar, S., Patil, K., Gairola, S., Dunachie, S., Merchant, H., Stokes, R., Kuwana, R., Maes, A., Charrier, J.-P., Probert, F., … Gangadharan, B. (2025). Npj Vaccines, 10(1).
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV).
Jittamala, P., Boyd, S., Schilling, W., Watson, J., Ngamprasertchai, T., Siripoon, T., Luvira, V., Batty, E., Wongnak, P., Esper, L., Almeida, P., Cruz, C., Ascencao, F., Aguiar, R., Ghanchi, N., Callery, J., Singh, S., Kruabkontho, V., Ngernseng, T., … PLATCOV Collaborative Group. (2025). EClinicalMedicine, 80, 103036.
MicroRNA in neuroexosome as a potential biomarker for HIV-associated neurocognitive disorders
Arizono, K., Sedohara, A., Tuvshinjargal, K., Tanaka, T., Koga, M., Nakahara, F., Ootani, A., Kanno, Y., Ikeuchi, K., Saito, M., Adachi, E., Tsutsumi, T., & Yotsuyanagi, H. (2025). Journal of NeuroVirology, 1-19.
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.
Esmaeili, S., Owens, K., Standing, J., Lowe, D., Zhang, S., Watson, J., Schilling, W., Wagoner, J., Polyak, S., & Schiffer, J. (2025).
Treatment and treatment outcomes of snakebite envenoming in Uganda: a retrospective analysis.
Nanyonga, S., Matafwali, S., Kibira, D., & Kitutu, F. (2025). Transactions of the Royal Society of Tropical Medicine and Hygiene, trae112.
Probabilistic classification of late treatment failure in uncomplicated malaria
Mehra, S., Taylor, A., Imwong, M., White, N., & Watson, J. (2025). In medRxiv.
A systematic review of the noma evidence landscape: current knowledge and gaps
Maguire, B., Shrestha, R., Dahal, P., Ngu, R., Nizigama, L., Rashan, S., Shrestha, P., Harriss, E., Newton, P., Makino, Y., Varenne, B., & Guérin, P. (2025). In medRxiv.
A protocol for a systematic review and individual patient data meta-analysis investigating the relationship betweenPfkelch13mutations and response to artemisinin-based treatment for uncomplicated falciparum malaria
van Wyk, S., Dahal, P., Christevy Vouvoungui, J., Ayuen, D., Shokraneh, F., Aboubakar, S., Watson, J., Guerin, P., & Barnes, K. (2025). In medRxiv.
Mental Health Services for Serious Mental Illness: Scoping Review of Randomised Controlled Trials.
Roson Rodriguez, P., Chen, X., Arancibia, M., Madrid, E., Shokraneh, F., Adams, C., & Franco, J. (2025). Nursing Open, 12(1), e70100.
Enhancer of zeste homolog 1/2 dual inhibitor valemetostat outperforms enhancer of zeste homolog 2-selective inhibitors in reactivating latent HIV-1 reservoirs <i>ex vivo</i>.
Sedohara, A., Koibuchi, T., Yamagishi, M., Koga, M., Arizono, K., Ikeuchi, K., Kikuchi, T., Saito, M., Adachi, E., Tsutsumi, T., Honma, D., Araki, K., Uchimaru, K., & Yotsuyanagi, H. (2025). Frontiers in Microbiology, 16, 1581330.
Modeling the within-host dynamics of <i>Plasmodium vivax</i> hypnozoite activation: An analysis of the SPf66 vaccine trial.
Mehra, S., Nosten, F., Luxemburger, C., White, N., & Watson, J. (2024). Proceedings of the National Academy of Sciences of the United States of America, 121(51), e2401024121.